PortalPublikationenRadio-tympano-sinu-orthesis with 186Re-colloid: a new treatm...

Radio-tympano-sinu-orthesis with 186Re-colloid: a new treatment modality for chronic otitis media and paranasal mucositis.

Standard

Radio-tympano-sinu-orthesis with 186Re-colloid: a new treatment modality for chronic otitis media and paranasal mucositis. / Kampen, Willm U; Godbersen, Godber S; Czech, Norbert; Besch, Otto F; Brenner, Winfried; Henze, Eberhard.

in: J NUCL MED, Jahrgang 44, Nr. 4, 4, 2003, S. 559-564.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Kampen, WU, Godbersen, GS, Czech, N, Besch, OF, Brenner, W & Henze, E 2003, 'Radio-tympano-sinu-orthesis with 186Re-colloid: a new treatment modality for chronic otitis media and paranasal mucositis.', J NUCL MED, Jg. 44, Nr. 4, 4, S. 559-564. <http://www.ncbi.nlm.nih.gov/pubmed/12679400?dopt=Citation>

APA

Kampen, W. U., Godbersen, G. S., Czech, N., Besch, O. F., Brenner, W., & Henze, E. (2003). Radio-tympano-sinu-orthesis with 186Re-colloid: a new treatment modality for chronic otitis media and paranasal mucositis. J NUCL MED, 44(4), 559-564. [4]. http://www.ncbi.nlm.nih.gov/pubmed/12679400?dopt=Citation

Vancouver

Kampen WU, Godbersen GS, Czech N, Besch OF, Brenner W, Henze E. Radio-tympano-sinu-orthesis with 186Re-colloid: a new treatment modality for chronic otitis media and paranasal mucositis. J NUCL MED. 2003;44(4):559-564. 4.

Bibtex

@article{bc66b74decb641a6bd97eecfd31d9bb3,
title = "Radio-tympano-sinu-orthesis with 186Re-colloid: a new treatment modality for chronic otitis media and paranasal mucositis.",
abstract = "This preliminary treatment trial was performed to evaluate the safety and clinical efficacy of intracavitary therapy with (186)Re-colloid in patients with recurrent otitis media and paranasal sinusitis, resistant to pharmacotherapy and surgical treatment. METHODS: Thirty-nine applications of 5-35 MBq (186)Re-colloid into the tympanon and the paranasal sinuses were performed in 6 patients. Biodistribution and biokinetics were studied by gamma-camera imaging. Clinical success was documented 6-20 mo after therapy by each patient's self-evaluation and by rhinootologic follow-up, using a 4-step score. RESULTS: No harmful side effects were seen. There was good-to-excellent clinical improvement with a score of +1.44 +/- 0.5 by each patient's self-evaluation and by physicians scoring of +0.81 +/- 0.9 with only negligible extracranial tracer deposition. CONCLUSION: This novel treatment option using intracavitary application of (186)Re-colloid in chronic otitis media and sinusitis is safe and effective. The term {"}radio-tympano-sinu-orthesis{"} might be proposed analogously to the well-known radiosynoviorthesis.",
author = "Kampen, {Willm U} and Godbersen, {Godber S} and Norbert Czech and Besch, {Otto F} and Winfried Brenner and Eberhard Henze",
year = "2003",
language = "Deutsch",
volume = "44",
pages = "559--564",
journal = "J NUCL MED",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "4",

}

RIS

TY - JOUR

T1 - Radio-tympano-sinu-orthesis with 186Re-colloid: a new treatment modality for chronic otitis media and paranasal mucositis.

AU - Kampen, Willm U

AU - Godbersen, Godber S

AU - Czech, Norbert

AU - Besch, Otto F

AU - Brenner, Winfried

AU - Henze, Eberhard

PY - 2003

Y1 - 2003

N2 - This preliminary treatment trial was performed to evaluate the safety and clinical efficacy of intracavitary therapy with (186)Re-colloid in patients with recurrent otitis media and paranasal sinusitis, resistant to pharmacotherapy and surgical treatment. METHODS: Thirty-nine applications of 5-35 MBq (186)Re-colloid into the tympanon and the paranasal sinuses were performed in 6 patients. Biodistribution and biokinetics were studied by gamma-camera imaging. Clinical success was documented 6-20 mo after therapy by each patient's self-evaluation and by rhinootologic follow-up, using a 4-step score. RESULTS: No harmful side effects were seen. There was good-to-excellent clinical improvement with a score of +1.44 +/- 0.5 by each patient's self-evaluation and by physicians scoring of +0.81 +/- 0.9 with only negligible extracranial tracer deposition. CONCLUSION: This novel treatment option using intracavitary application of (186)Re-colloid in chronic otitis media and sinusitis is safe and effective. The term "radio-tympano-sinu-orthesis" might be proposed analogously to the well-known radiosynoviorthesis.

AB - This preliminary treatment trial was performed to evaluate the safety and clinical efficacy of intracavitary therapy with (186)Re-colloid in patients with recurrent otitis media and paranasal sinusitis, resistant to pharmacotherapy and surgical treatment. METHODS: Thirty-nine applications of 5-35 MBq (186)Re-colloid into the tympanon and the paranasal sinuses were performed in 6 patients. Biodistribution and biokinetics were studied by gamma-camera imaging. Clinical success was documented 6-20 mo after therapy by each patient's self-evaluation and by rhinootologic follow-up, using a 4-step score. RESULTS: No harmful side effects were seen. There was good-to-excellent clinical improvement with a score of +1.44 +/- 0.5 by each patient's self-evaluation and by physicians scoring of +0.81 +/- 0.9 with only negligible extracranial tracer deposition. CONCLUSION: This novel treatment option using intracavitary application of (186)Re-colloid in chronic otitis media and sinusitis is safe and effective. The term "radio-tympano-sinu-orthesis" might be proposed analogously to the well-known radiosynoviorthesis.

M3 - SCORING: Zeitschriftenaufsatz

VL - 44

SP - 559

EP - 564

JO - J NUCL MED

JF - J NUCL MED

SN - 0161-5505

IS - 4

M1 - 4

ER -